-
Mashup Score: 0Adding Pembrolizumab to Platinum and Pemetrexed Improves OS in Treatment-Naive MPM - ILCN.org (ILCN/WCLC) - 10 month(s) ago
Dr. Quincy Chu recently shared results from the phase III IND227 trial, which also demonstrated improved progression-free survival in mesothelioma patients who received the combination compared to those who received standard chemotherapy alone.
Source: ILCN.org (ILCN/WCLC)Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Artificial Intelligence in Healthcare: A Patient Perspective - ILCN.org (ILCN/WCLC) - 10 month(s) ago
When life-and-death decisions are at stake, will patients welcome AI to their care team? As part of ILCN’s series on AI in lung cancer, patient advocate Angus Pratt explores issues of trust, safety, accuracy, and more.
Source: ILCN.org (ILCN/WCLC)Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Demystifying AI: Current Insights on Artificial Intelligence in Thoracic Oncology - ILCN.org (ILCN/WCLC) - 10 month(s) ago
Dr. Raymond Mak and Fridolin Haugg delve into the artificial intelligence discussion with an overview of AI basics and a look at how AI is already influencing the lung cancer field.
Source: ILCN.org (ILCN/WCLC)Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0In Brief for June 28, 2023 - ILCN.org (ILCN/WCLC) - 10 month(s) ago
Canada to require health warnings on cigarettes. US FDA approves application for pemetrexed injection, grants priority review for repotrectinib.
Source: ILCN.org (ILCN/WCLC)Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1IASLC Announces Results of 2023 Board of Directors Election - ILCN.org (ILCN/WCLC) - 10 month(s) ago
The newly elected board members, including President-Elect Dr. Caicun Zhou, will assume their roles at the upcoming 2023 World Conference on Lung Cancer in Singapore.
Source: ILCN.org (ILCN/WCLC)Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0International Group Consensus Statement Offers Technical Guidance for MPM Imaging - ILCN.org (ILCN/WCLC) - 10 month(s) ago
Dr. Sharyn Katz and colleagues summarize key recommendations for improving imaging quality in malignant pleural mesothelioma.
Source: ILCN.org (ILCN/WCLC)Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Tumor Treating Fields May Provide Additional Treatment Option for mNSCLC Following Progression - ILCN.org (ILCN/WCLC) - 10 month(s) ago
Investigator Ticiana Leal, MD, said the the phase III LUNAR study met its primary endpoint and demonstrated a statistically significant 3-month improvement in median overall survival versus the standard of care.
Source: ILCN.org (ILCN/WCLC)Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0From the Editors: Those in Thoracic Oncology Field Must Educate Themselves About Artificial Intelligence - ILCN.org (ILCN/WCLC) - 10 month(s) ago
Like it or not, AI will be part the diagnostic and therapeutic landscape, and it is incumbent on clinicians to understand its implications, limitations, and benefits, ILCN editors say.
Source: ILCN.org (ILCN/WCLC)Categories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 0From the Editors: Those in Thoracic Oncology Field Must Educate Themselves About Artificial Intelligence - ILCN.org (ILCN/WCLC) - 11 month(s) ago
Like it or not, AI will be part the diagnostic and therapeutic landscape, and it is incumbent on clinicians to understand its implications, limitations, and benefits, ILCN editors say.
Source: ILCN.org (ILCN/WCLC)Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4From the Editors: Defining Resectability of Non-Small Cell Lung Cancer in 2023 - ILCN.org (ILCN/WCLC) - 11 month(s) ago
Is “resectability” based on radical resection criteria still valid in the era of neoadjuvant immunochemotherapy? ILCN’s editors say the term needs to be revisited and probably redefined based on a tumor’s status before treatment and after neoadjuvant treatment.
Source: ILCN.org (ILCN/WCLC)Categories: Hem/Oncs, Latest HeadlinesTweet
During #ASCO23, Dr. Quincy Chu presented results from the phase III IND227 trial of malignant pleural mesothelioma treatment options. Read a recap in #ILCN: https://t.co/EBchlaHVan #LCSM https://t.co/a0RZIXvHUm